Renatus Tactical Acquisition Corp I is a special purpose acquisition company formed to pursue a business combination with one or more operating companies. It has no significant standalone operations and holds IPO proceeds largely in trust until a deal is completed. Management has indicated a primary interest in partnering with innovative technology businesses, while retaining flexibility across sectors.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 0 | — | 0 | — |
| Q2 2025 | 0 | — | 0.8 | — |
| Q3 2025 | 0 | — | 2.2 | — |
| Q4 2025 | 0 | — | 2.1 | — |
| Q1 2026 | 0 | — | 1.8 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: Galectin Therapeutics Inc. (GALT), G. Willi-Food International Ltd. (WILC), Parke Bancorp, Inc. (PKBK), Larimar Therapeutics, Inc. (LRMR), Gladstone Land Corporation (LAND), Everspin Technologies, Inc. (MRAM)